Key points are not available for this paper at this time.
GPA patients experience a greater than expected number of specific malignancies following conventional therapies. Our analyses demonstrate a substantially increased risk of very late-occurring NMSC and bladder cancer in this patient group.
Faurschou et al. (Wed,) studied this question.